- Joined
- Apr 12, 2007
- Messages
- 593
- Reaction score
- 174
http://www.asahq.org/For the Public and Media/Press Room/ASA News/Choosing Wisely.aspx
From the ASA campaign the top 5
1. Dont obtain baseline laboratory studies in patients without significant systemic disease (ASA I or II) undergoing low-risk surgery specifically complete blood count, basic or comprehensive metabolic panel, coagulation studies when blood loss (or fluid shifts) is/are expected to be minimal.
2 Dont obtain baseline diagnostic cardiac testing (trans-thoracic/esophageal echocardiography TTE/TEE) or cardiac stress testing in asymptomatic stable patients with known cardiac disease (e.g., CAD, valvular disease) undergoing low or moderate risk non-cardiac surgery.
3 Dont use pulmonary artery catheters (PACs) routinely for cardiac surgery in patients with a low risk of hemodynamic complications (especially with the concomitant use of alternative diagnostic tools (e.g., TEE).
4 Dont administer packed red blood cells (PRBCs) in a young healthy patient without ongoing blood loss and hemoglobin of ≥ 6 g/dL unless symptomatic or hemodynamically unstable.
5 Dont routinely administer colloid (dextrans, hydroxylethyl starches, albumin) for volume resuscitation without appropriate indications.
Any objections?
I can tell you that many of colleagues will cancel/delay a cases for #2. Most want cardiology to comment of likelihood of an event.
#3 I still have trouble convincing our surgeons that a PAC in not needed in healthy mitral valve patients let alone CABG or AVRs
#5 i am in complete agreement with, Albumin is way overused and many still quote a 3:1 replacement when the SAFE trial showed in sepsis it was more like 1.4:1
From the ASA campaign the top 5
1. Dont obtain baseline laboratory studies in patients without significant systemic disease (ASA I or II) undergoing low-risk surgery specifically complete blood count, basic or comprehensive metabolic panel, coagulation studies when blood loss (or fluid shifts) is/are expected to be minimal.
2 Dont obtain baseline diagnostic cardiac testing (trans-thoracic/esophageal echocardiography TTE/TEE) or cardiac stress testing in asymptomatic stable patients with known cardiac disease (e.g., CAD, valvular disease) undergoing low or moderate risk non-cardiac surgery.
3 Dont use pulmonary artery catheters (PACs) routinely for cardiac surgery in patients with a low risk of hemodynamic complications (especially with the concomitant use of alternative diagnostic tools (e.g., TEE).
4 Dont administer packed red blood cells (PRBCs) in a young healthy patient without ongoing blood loss and hemoglobin of ≥ 6 g/dL unless symptomatic or hemodynamically unstable.
5 Dont routinely administer colloid (dextrans, hydroxylethyl starches, albumin) for volume resuscitation without appropriate indications.
Any objections?
I can tell you that many of colleagues will cancel/delay a cases for #2. Most want cardiology to comment of likelihood of an event.
#3 I still have trouble convincing our surgeons that a PAC in not needed in healthy mitral valve patients let alone CABG or AVRs
#5 i am in complete agreement with, Albumin is way overused and many still quote a 3:1 replacement when the SAFE trial showed in sepsis it was more like 1.4:1